September 27, 2016 4:06 PM ET

Pharmaceuticals

Company Overview of Cerebrus Pharmaceuticals Limited

Company Overview

As of December 3, 1999, Cerebrus Pharmaceuticals Limited was acquired by Vernalis Group Plc. Cerebrus Pharmaceuticals Limited ('Cerebrus'), is the principal operating subsidiary of Cerebrus plc. Cerebrus is an unquoted emerging pharmaceutical company, specialising in the discovery and development of novel therapeutics for disabling and life threatening disorders of the central nervous system. It has entered a research and development collaboration with Roche to develop anti-obesity drugs, agreeing to license the same to F. Hoffmann-La Roche Ltd, its serotin receptor based program. Cerebrus has substantial expertise in the field of obesity, serotonin chemistry and pharmacology. The obesity pr...

London,  

United Kingdom

Key Executives for Cerebrus Pharmaceuticals Limited

Cerebrus Pharmaceuticals Limited does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cerebrus Pharmaceuticals Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.